Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8274144 | Journal of the Neurological Sciences | 2016 | 6 Pages |
Abstract
The current utilization rate of intravenous thrombolysis of 2% has minimal population impact. Increasing the rate of utilization to more than 12% is the minimum to have a significant population effect on disability and should be a public policy aim.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Lorena Hoffmeister, Pablo M. Lavados, Javier Mar, Merce Comas, Arantzazu Arrospide, Xavier Castells,